SB 502-FN (2018): relative to transparency and standards for acquisition transactions in health care.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA
“SB 502-FN (2018): relative to transparency and standards for acquisition transactions in health care.” Granite Record, https://graniterecord.org/bill/2018/sb502. Accessed 24 Oct. 2026.
APA
Granite Record. (n.d.). SB 502-FN (2018): relative to transparency and standards for acquisition transactions in health care. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2018/sb502
Chicago
Granite Record. “SB 502-FN (2018): relative to transparency and standards for acquisition transactions in health care.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2018/sb502.
BibTeX
@misc{bill-2018-sb502, title = {SB 502-FN (2018): relative to transparency and standards for acquisition transactions in health care.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2018/sb502}, note = {Accessed 24 Oct. 2026} }

SB 502-FN (2018)

relative to transparency and standards for acquisition transactions in health care.

  • Status: Referred for interim study
  • Term: 2017-2018
  • House committee: Commerce and Consumer Affairs
  • Senate committee: Judiciary
  • Subject: Miscellaneous

The Story

It was introduced on January 3, 2018 and referred to the Senate Judiciary committee. The committee recommended that the Senate pass it. On February 22, 2018 the Senate voted to pass it on a voice vote and ordered it to a third reading. It crossed to the House on March 7, 2018 and was referred to the House Commerce and Consumer Affairs committee. The committee held a public hearing on March 27, 2018. The committee held work sessions on April 4, 2018, April 11, 2018 and April 17, 2018. The committee met in executive session on April 17, 2018 to vote on its recommendation. The committee held work sessions on April 18, 2018 and April 24, 2018. The committee met in executive session on April 24, 2018 to vote on its recommendation. The minority of the committee recommended that the House pass it. The majority of the committee recommended that the House study it after the session ends by a vote of 11–7, and the report was placed on the regular calendar. On May 2, 2018 the House voted to study it after the session ends on a roll call 170–160. The committee held a work session on September 18, 2018. The committee met in executive session on October 2, 2018 to vote on its recommendation. The committee reported back on its interim study of the bill: “Not Recommended for Future Legislation”, by a vote of 9 to 8.

Sponsors

Hearings and Sessions

  • January 16, 2018, 9:50 AM: hearing, Senate Judiciary, SH 100
  • March 27, 2018, 1:45 PM: public hearing, House Commerce and Consumer Affairs, LOB 302
  • April 4, 2018, 1:15 PM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302
  • April 11, 2018, 1:45 PM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302
  • April 17, 2018, 10:00 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 304
  • April 17, 2018, 1:30 PM: executive session, House Commerce and Consumer Affairs, LOB 302
  • April 18, 2018, 10:00 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302
  • April 24, 2018: executive session, House Commerce and Consumer Affairs, LOB 302
  • April 24, 2018, 10:00 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302
  • September 18, 2018, 1:00 PM: subcommittee work session, House Commerce and Consumer Affairs, LOB304
  • October 2, 2018, 1:30 PM: executive session, House Commerce and Consumer Affairs, LOB302

Votes

  • February 22, 2018, Senate: Ought to Pass — voice vote, passed
  • May 2, 2018, House: Interim Study — yeas 170, nays 160, passed

The Docket

  • January 3, 2018: To Be Introduced 01/03/2018 and Referred to Judiciary
  • January 16, 2018: Hearing: 01/16/2018, Room 100, SH, 09:50 am; SC 2A
  • February 22, 2018: Committee Report: Ought to Pass, 02/22/2018
  • February 22, 2018: Ought to Pass : MA, VV; OT3rdg; 02/22/2018
  • March 7, 2018: Introduced 03/07/2018 and referred to Commerce and Consumer Affairs
  • March 27, 2018: Public Hearing: 03/27/2018 01:45 PM LOB 302
  • April 4, 2018: Subcommittee Work Session: 04/04/2018 01:15 PM LOB 302
  • April 11, 2018: Subcommittee Work Session: 04/11/2018 01:45 PM LOB 302
  • April 17, 2018: Subcommittee Work Session: 04/17/2018 10:00 AM LOB 304
  • April 17, 2018: Executive Session: 04/17/2018 01:30 PM LOB 302
  • April 18, 2018: Subcommittee Work Session: 04/18/2018 10:00 AM LOB 302
  • April 24, 2018: Subcommittee Work Session: 04/24/2018 10:00 AM LOB 302
  • April 24, 2018: Executive Session: 04/24/2018 LOB 302
  • April 25, 2018: Minority Committee Report: Ought to Pass
  • May 2, 2018: Majority Committee Report: Refer for Interim Study for 05/02/2018 (Vote 11-7; RC)
  • May 2, 2018: Refer for Interim Study: MA RC 170-160 05/02/2018
  • September 18, 2018: Interim Study Subcommittee Work Session: 09/18/2018 01:00 PM LOB304
  • October 2, 2018: Executive Session: 10/02/2018 01:30 PM LOB302
  • October 29, 2018: Interim Study Report: Not Recommended for Future Legislation (Vote 9-8)

Laws It Would Change

Related Bills

  • HB 552-FN (2019): relative to transparency and standards for acquisition transactions in health care.

From the General Court